P. Moullier et al., CORRECTION OF LYSOSOMAL STORAGE IN THE LIVER AND SPLEEN OF MPS-VII MICE BY IMPLANTATION OF GENETICALLY-MODIFIED SKIN FIBROBLASTS, Nature genetics, 4(2), 1993, pp. 154-159
Genetic defects of lysosomal hydrolases result in severe storage disea
ses and treatments based on enzyme replacement have been proposed. In
mice lacking beta-glucuronidase, which develop a disease homologous to
human mucopolysaccharidosis type VII (Sly syndrome), we have used aut
ologous implants of genetically-modified skin fibroblasts for the cont
inuous in vivo production of the enzyme. The human beta-glucuronidase
cDNA was introduced with a retroviral vector into mutant mice skin fib
roblasts grown in primary culture. Fourteen mutant mice were implanted
intraperitoneally with these modified cells embedded into collagen la
ttices. All animals expressed beta-glucuronidase from the vascularized
neo-organs that developed after implantation and accumulated the enzy
me in their tissues. A complete disappearance of the lysosomal storage
lesions was observed in their liver and spleen.